Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Thiomersal-Free Influenza Vaccine in Children
NCT00731393Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2003
- Primary completion
- Aug 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of trivalent influenza split vaccine in influenza, sponsored by GSK. Started Oct 2003; status: completed.
02
Drugs
trivalent influenza split vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00731393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731393.